Draegerwerk AG & Co KGaA Vorz.Akt. ohne Stimmrecht DRW3
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €49.05
- Day Range
- €48.50–49.30
- 52-Week Range
- €41.75–56.20
- Bid/Ask
- €48.80 / €0.00
- Market Cap
- €916.43 Mil
- Volume/Avg
- 12,754 / 10,264
Key Statistics
- Price/Earnings (Normalized)
- 4.15
- Price/Sales
- 0.27
- Dividend Yield (Trailing)
- 0.37%
- Dividend Yield (Forward)
- 3.54%
- Total Yield
- 0.49%
Company Profile
Draegerwerk AG & Co KGaA develops medical and safety equipment for clinical and industrial applications. The firm operates in two segments: medical and safety. The medical division contributes the majority of revenue, it develops and produces system solutions, equipment, and services for the acute point of care, it has five business units Therapy, Hospital Consumables & Accessories, Workplace Infrastructure, Monitoring, and Data Business. Its safety division develops and produces devices, system solutions, and services for personal protection, gas detection, and integrated hazard management. Its geographical segments are Europe; Germany; the Americas; Africa, Asia, and Australia.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 16,329
- Website
- https://www.draeger.com
Comparables
Valuation
|
Metric
|
DRW3
|
CHG
|
SYAB
|
|---|---|---|---|
Price/Earnings (Normalized) | 4.15 | 1,906.69 | 80.88 |
Price/Book Value | 0.65 | 3.93 | 0.99 |
Price/Sales | 0.27 | 6.28 | 0.88 |
Price/Cash Flow | 3.32 | 32.87 | 8.25 |
Price/Earnings
DRW3
CHG
SYAB
Financial Strength
|
Metric
|
DRW3
|
CHG
|
SYAB
|
|---|---|---|---|
Quick Ratio | 1.13 | 2.54 | 1.03 |
Current Ratio | 1.83 | 3.00 | 1.16 |
Interest Coverage | 5.54 | −2.35 | 2.17 |
Quick Ratio
DRW3
CHG
SYAB
Profitability
|
Metric
|
DRW3
|
CHG
|
SYAB
|
|---|---|---|---|
Return on Assets (Normalized) | 7.78% | 0.11% | 0.86% |
Return on Equity (Normalized) | 17.44% | 0.21% | 1.87% |
Return on Invested Capital (Normalized) | 14.66% | 1.14% | 2.44% |
Return on Assets
DRW3
CHG
SYAB
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Xyzbnptrf | Qfqqvw | $185.4 Bil | |
SYK
| Stryker Corp | Rkrykbnnz | Cqwh | $127.7 Bil | |
BSX
| Boston Scientific Corp | Hkbtxflpx | Fnvytx | $107.6 Bil | |
MDT
| Medtronic PLC | Pgkdhhmb | Rznfzs | $105.9 Bil | |
DXCM
| DexCom Inc | Wczpmxbdf | Dbk | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Wrssmxnpg | Fwygyd | $52.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Ljmrfwyrx | Zwdh | $24.6 Bil | |
ALGN
| Align Technology Inc | Hhktqvtm | Qsyth | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Byjwttkj | Wpwgfv | $18.7 Bil | |
PODD
| Insulet Corp | Scffgbxdz | Scjnvw | $11.6 Bil |